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Background: Neonatal mortality reduction in China over past two decades was reported from nationwide sampling
surveys, however, how high risk pregnancy affected neonatal outcome is unknown. The objective of this study was to
explore relations of pregnancy complications and neonatal outcomes from a regional birth population.
Methods: In a prospective, cross-sectional survey of complete birth population-based data file from 151 level I-III
hospitals in Huai’an region in 2010, pregnancy complications were analyzed for perinatal morbidity and mortality
in association with maternal and perinatal characteristics, hospital levels, mode of delivery, newborn birth weight
and gestational age, using international definition for birth registry and morbidities.
Results: Pregnancy complications were found in 10% of all births, in which more than 70% were delivered at level
II and III hospitals associated with higher proportions of fetal and neonatal death, preterm birth, death at delivery
and congenital anomalies. High Cesarean section delivery was associated with higher pregnancy complications,
and more neonatal critical illnesses. The pregnancy complications related perinatal morbidity and mortality in level III
were 2–4 times as high as in level I and II hospitals. By uni- and multi-variate regression analysis, impact of pregnancy
complications was along with congenital anomalies and preterm birth, and maternal child-bearing age and school
education years contributing to the prevalence.
Conclusions: This survey revealed variable links of pregnancy complications to perinatal outcome in association with
very high Cesarean section deliveries, which warrants investigation for causal relations between high risk pregnancy
and neonatal outcome in this emerging region.
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In the past decade there has been a dramatic decline in
mortality of children under 5 years old in China, from
60/1,000 in early 1990 to a level below 15/1,000 live
births in 2012 as recently reported by the National Health
and Family Planning Commission (www.nhfpc.gov.cn,
2013 July), in great extent associated with the reduction of* Correspondence: bsun98@aliyun.com
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unless otherwise stated.neonatal mortality [1-8], i.e., from 40/1,000 to <7/1,000
live births, along with significantly reduced maternal death
rate (<25/100,000 births) and narrowed disparities be-
tween rural and urban death rates. This was mainly due
to effective implementation of prenatal care from early
pregnancy, hospital delivery, delivery room resuscitation
and neonatal special care, and medications for infec-
tious diseases, diarrhea and malnutrition, among others
[7-13]. Although national vital statistics revealed this
trend, it is not known yet on how the high risk pregnancy
would link to perinatal and neonatal death rate in total
births and live births. As there are great variations in
different regions in China, and perinatal and neonatal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tality by 60-70%, how to improve the perinatal and
neonatal survival is a big challenge not only for the
health care givers and clinical technology, but also
public health care administrators and practitioners,
policy makers, and child welfare, special care and educa-
tion professionals in the whole society and local commu-
nities. A variety of questions are raised from potential
burden in technologies and resource to ethics regarding
limit of viability, where lacking of systematic information
and reporting, diagnostic means and care standard, re-
sources of public health care system, and staff compe-
tence and availability at community level, etc., are
commonly encountered but compelling to find solu-
tions for sustainability in the current development in
developing countries.
There is no complete birth-population-based regional
or provincial data of survey available so far regarding
high risk pregnancy contributing to the perinatal and
neonatal morbidity and mortality. Existing information
come mostly from surveys based on the approaches by
sampling of selected level II hospitals of rural counties
and urban districts for total births and related death
causes, which provided estimated nation-wide data [7,8],
but may not provide perinatally associated maternal-fetal
and neonatal disease incidence and death rate from
different hospital level based information, neither is valid
for estimation of nation-wide perinatal and neonatal
morbidity and mortality appropriate to the need of
country’s development. Besides, in the nation-wide report-
ing system for regional vital statistics, the births earlier
than 29 weeks of gestational age (GA) are not included
whereas advanced neonatal special care at regional and
county/city hospitals is common now in many emerging
regions for neonates born before 29 weeks of GA or
<1,000 g of birth weight (BW) to survive. Therefore, it
does not provide perinatal and neonatal information
associated with pregnant status and complications, or in-
cidence, management and outcome (death and complica-
tions) of specific maternal-fetal and neonatal disorders.
Neither does it provide information of how many deaths
are related to inappropriate coverage of prenatal care in
regions with different levels of health care service. Thus,
listing of neonatal death rate and their causes only has
shown a trend of changes in neonatal death and under-
lying causes, but lacks comprehensive view as to what ex-
tent the obstetric and neonatal clinic performance as well
as regional public health policy and resource really con-
tribute to the overall and specific neonatal outcome. Consid-
ering the high birth population and dramatic improvement
of perinatal and neonatal care in many emerging regions of
the country, an in-depth study of high risk pregnancy and
prenatal morbidity related fetal and neonatal outcome is
compelling. In this regard, we prospectively conducted aregional complete birth population-based, cross-sectional
survey in combination with most, if not all, of the hospital-
ized high risk pregnancies and neonates with various dis-
eases, which provides information including high risk
pregnancy contributing to the perinatal-neonatal morbidity
and mortality using epidemiological methodology in Huai’an
[14], Jiangsu province, China.
The objective of this analysis from the cross-sectional
survey-based descriptive data was to delineate high risk
pregnancy linking to the fetal and neonatal morbidity
and mortality. Characterizing the incidence of prenatal
and intrapartum complications, mode of delivery associated
perinatal and neonatal risks and outcomes from regional
hospitals may facilitate an estimation of nation-wide preg-
nancy and childbirth related efficacy of policies, strategies
and programs as well as burden and resource limitation,
for understanding the trend and perspectives of woman
and child health care development in China.Methods
Summary of study region and population
The survey was conducted in Huai’an city, a prefectural
region, Jiangsu province, located in the eastern part of
China with a population of 5,400,000 and nearly 60,000
births in 2009, with approximately 5% migrant people
for seasonal, economic living in this region. There were
almost equal proportion of residents from both urban
and rural origin, and economic levels, judged by gross
domestic production per head, were similar to that of
the national averages in 2010. Its socio-cultural tradition
was also representative of average in most of the east
and midland provinces of the country. We assumed that
a cross-sectional, perinatal-neonatal survey in Huai’an
region should represent the situation in most emerging
regions of China, with intermediate development in both
economics and woman and child health care, presumably
accounting for up to 50% of the total Chinese population
(1.34 billion in 2010 census), as characterized by high
hospital delivery (>99%), health insurance for most
rural residents (>95%) and health care infrastructure
for coverage and availability.Synopsis of the study protocol
Details of the collaborative study group for perinatal-
neonatal care in Huai’an region, data collection and quality
control was reported elsewhere [14], and are summarized
below:
Study setting: 151 level I-III hospitals (Table 1) pro-
viding child delivery and neonatal care service (level
II-III hospitals).
Study design: prospective, cross-sectional survey of
complete birth data from hospital deliveries including
pregnancy complications and perinatal morbidities.
Table 1 Comparison of all child births and related morbidity and mortality in different levels of hospitals in Huai’an
Hospital level I II III P
Number of hospitals 129 15 7
All births 31,680 (52.3) 19,767 (32.6) 9,168 (15.1)
Fetal deaths/stillbirth 36 (0.1) 143 (0.7) 71 (0.8)
Live births 31,644 (99.9) 19,624 (99.3) 9,097 (99.2)
Males 16,900 (53.5) 10,539 (53.5) 4,967 (55.1) 0.018
Gestational age (weeks) 39.9±1.2 39.6±1.5 39.0±2.1 <0.001
Birthweight (grams) 3,469±447 3,443±495 3,338±604 <0.001
Preterm births 404 (1.3) 776 (3.9) 1,059 (11.6) <0.001
Low birthweight 395 (1.2) 545 (2.8) 751 (8.3) <0.001
Multiple-births 300 (0.9) 385 (1.9) 403 (4.4) <0.001
Congenital anomalies 117 (0.4) 119 (0.6) 78 (0.9) <0.001
Cesarean section 15,566 (49.2) 11,155 (56.6) 5,243 (57.5) <0.001
Pregnancy complications 1,766 (5.6) 2,380 (12.1) 1,905 (21.1) <0.001
Hypertension 327 (1.0) 410 (2.1) 279 (3.0) <0.001
PROM 1,062 (3.3) 1,211 (6.1) 1,017 (11.1) <0.001
Anemia 236 (0.7) 363 (1.8) 147 (1.6) <0.001
Maternal age (years) 25.5±5.2 26.1±5.1 26.7±4.9 <0.001
Delayed childbearing 2,543 (8.1) 1,698 (8.6) 824 (9.0) 0.006
>9 years’ education 2,223 (7.4) 4,261 (23.2) 3,855 (50.0) <0.001
Amniotic fluid volume <0.001
Normal 29,162 (93.4) 18,037 (92.2) 7,665 (90.6)
Polyhydramnios 192 (0.6) 134 (0.7) 150 (1.8)
Oligohydramnios 1,873 (6.0) 1,400 (7.2) 647 (7.6)
Amniotic contamination <0.001
Normal 27,647 (87.5) 16,240 (82.5) 7,639 (86.8)
Grade I 1,845 (5.8) 1,105 (5.6) 286 (3.2)
Grade II 1,356 (4.3) 1,069 (5.4) 324 (3.7)
Grade III 732 (2.3) 1260 (6.4) 548 (6.2)
Apgar score
1-min ≤7 783 (2.5) 767 (3.9) 740 (8.2) <0.001
1-min ≤3 75 (0.2) 176 (0.9) 98 (1.1) <0.001
5-min ≤7 105 (0.3) 193 (1.0) 244 (2.7) <0.001
5-min ≤3 35 (0.1) 137 (0.7) 64 (0.7) <0.001
Deathsa 56 (0.2) 156 (0.8) 90 (1.0) <0.001
All values are given in numbers and percentage (% of all births in each hospital level category) or means±SD. Definition of abbreviations: PROM, premature
rupture of membrane.
aIncluding fetal deaths/stillbirth and neonatal deaths immediately at delivery but counted as live births.
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birth and live births collected from Jan 1 to Dec 31, 2010.
Sample size: based on 2009 total births number, it is
estimated to be 60,000-61,000 from hospital deliveries in
the whole year 2010.
Data collection: for all the hospital deliveries, each
birth should have a case record form to be collected
through regional perinatal-neonatal information networksystem, and assisted by co-investigators and task force
group members from most level II and III hospital ob-
stetric and pediatric departments and outreaching
local (county and district) level I hospitals and clinic
services.
Study variables: maternal, fetal and neonatal biological
and clinical pathological variables on prenatal, intrapartum,
and postnatal examinations, interventions and outcome.
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Committee and Scientific Committee of the Children’s
Hospital of Fudan University, and adopted by all the
participating hospitals through local scientific committee
approval according to Chinese regulation for clinical in-
vestigation. As data were collected from observational pa-
rameters and no specific intervention was used in the
protocol, informed consent was waived.
Definitions of vital statistics and perinatal morbidities
Live birth, fetal death or stillbirth, and death during
delivery are defined according to the 10th revision of
the international classification of diseases [15,16], and
details of birth related definitions such as GA, BW and
perinatal and neonatal death rate are described elsewhere
[14]. The perinatal period commences at 22 complete
weeks (154 days) of GA, ended at 7 postnatal days and the
neonatal period is the first 28 complete days after birth.
Fetal death is synonymous of stillbirth. The fetal status,
perinatal morbidities, birth defects (BD) or congenital
anomalies, and major neonatal diseases are defined ac-
cording to Fanaroff and Martin [17] and domestic clinical
criteria. The same applies for diagnosis of pregnancy com-
plications as obstetric pathologies of each pregnancy based
on both domestic criteria adopting internationally recog-
nized definitions [16], and presented as incidence rates
using numbers of total births as denominator. Incidence
of specific neonatal disease is expressed by using either
total live births as denominator or total hospitalized num-
bers as constitutive rate where appropriate [14].
Quality control
To ensure that all the records to be accurate and
complete, on-site physician/investigator and coordina-
tors cross checked all the variables and values, along
with visiting, telephone or e-mail communication, for
verification and correction of the data. General quality
control inspections were also provided for birth regis-
tration or medical records from all the municipal and
county hospitals, and 20% township hospitals [14].
Educational sessions were provided to ensure clinical
diagnosis and management conforming to the best avail-
able domestic criteria to each level of clinical service and
capacity.
Statistical analysis
The EPIDATA database was used for datasheet record-
ings and statistical analysis was performed using SPSS
software (v. 16.0, SPSS Inc. Chicago, IL). Numerical data
were presented by the mean (standard deviation, SD) or
median (interquartile range, IQR) where appropriate,
using one way analysis of variance for comparisons of
continuous variables between subset data. Categorical
variables were represented as frequencies or rates, usingChi square test for comparison of differences. A p
value <0.05 was considered statistically significant.
Missing data for each variable in the analysis ranged in
0.2-0.8% and were considered acceptable. For assess-
ment of relative risks of perinatal mortality associated
with pregnancy complications, perinatal morbidities
and neonatal status at birth, uni- and multi-variate logistic
regression analysis was performed for clinical variables.
Results are reported as odds ratio (OR) or relative risk and
95% confidence interval (CI).
Results
General conditions of total births and live births
Table 1 illustrates that all birth related maternal-fetal
and neonatal data, as well as birth delivery related morbid-
ities in three levels of the hospitals, and that 85% deliveries
were from level I and II hospitals. It also demonstrates
that more preterm birth with low BW, pregnancy compli-
cations, congenital anomalies, Apgar score ≤3 at 1-min
and 5-min, high risk newborns, and neonatal deaths at
delivery were seen at level II and III hospitals, suggesting
centralized management of high risk pregnancy and
delivery in the region.
Over the 12-month study period, there were totally
61,227 birth registries, with 99.6% (60,986) as live birth
in which 60,615 had birth information collected (99% of
the total births). The total birth rate was 11.3‰ (referenced
to 5,400,000). There were 32,406 (53.8%) males and 27,874
females in the total births, or a male-to-female ratio of
116:100. This ratio was even higher with increasing BW
strata or order of the births [14]. The information of GA
and BW related general and stratified data and analysis are
reported elsewhere [14]. Incidence of BD was found in
0.67% (411/60,986) including 88 (21.4%) cleft lip and palate,
53 (12.9%) finger or toe malformations, 47 (11.4%)
congenital heart disease (CHD), 35 (8.5%) neural tube
defects, 31 (7.5%) urogenital system malformations, 25
(6.1%) external ear malformations, 19 (4.6%) hydroceph-
alus, 19 (4.6%) alimentary system malformations, among
others. The BD rate decreased with increasing BW, male
being 0.73% and female 0.62% (p = 0.114), respectively.
Pregnancy complications
Overall 10% (6,051/60,445) deliveries had significantly
pregnancy complications as major risk factors such as
premature rupture of membrane (3,290, 5.4%), hyperten-
sion (1,016, 1.7%), anemia (746, 1.2%), preeclampsia (277,
0.4%), placenta previa (181), hepatitis (174), infection
(107), diabetes (85), cardiac diseases (82), placenta abrup-
tion (80), renal diseases (16), among others. Table 2 shows,
from all the deliveries, maternal and perinatal status with
and without major pregnancy complications. Prevalence
of Cesarean (C)-section, proportions of fetal death/
stillbirth, preterm birth, low birth weight, multiple births,
Table 2 Pregnancy complication related maternal and
fetal birth status
Pregnancy complications Yes No P values
All pregnancies 5,938 (10.0) 53,925 (90.0)
Maternal age (years) 26.7±5.6 25.8±5.1 <0.001
<20 136 (2.3) 1,348 (2.5)
20-24 2,483 (42.0) 26,168 (48.8)
25-29 1,872 (31.7) 15,566 (29.0)
30-34 712 (12.0) 6,228 (11.6)
>35 706 (11.9) 4,296 (8.0)
First delivery 4,093 (68.0) 34,921 (64.7) <0.001
Cesarean section 4,315 (71.6) 27,553 (50.8) <0.001
Fetal deaths/stillbirths 34 (0.6) 155 (0.3) <0.001
Birth numbers 6,051 (10.0) 54,394 (90.0)
Live births 6,017 (99.4) 54,239 (99.7)
Preterm births 860 (14.2) 1,370 (2.5) <0.001
32-36 weeks 759 (12.6) 1,174 (2.2)
28-31 weeks 96 (1.6) 170 (0.3)
24-27 weeks 5 26
Post-term births 90 (1.5) 1602 (3.0) <0.001
Low birthweight 541 (9.0) 1140 (2.1) <0.001
Multiple-births 224 (3.7) 859 (1.6) <0.001
Congenital anomalies 56 (0.9) 257 (0.5) <0.001
Deathsa 54 (0.9) 194 (0.4) <0.001
All values are given in numbers and percentage (% of all pregnancies or birth
numbers) or means±SD. aIncluding fetal deaths/stillbirth and neonatal deaths
immediately at delivery but counted as live births.
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death were significantly higher in those with pregnancy
complications than those without. Tables 3 and 4 illustrate
neonatal BW and GA strata associated pregnancy com-
plications, birth related death rate, gender, neonatal
morbidity and mortality. With increasing BW, more
males and C-section deliveries were getting higher whereas
preterm births, multiple births, congenital anomalies,
pregnancy complications, hospitalized infants, oxygen
therapy, mechanical ventilation, corticosteroid use, and
major morbidities were getting lower. The same trend
was true with increasing GA.
Table 5 demonstrates mode of delivery related perinatal
status and complications. In those by vaginal delivery,
there was 0.7% as dystocia requiring assisted operational
procedures. There was difference of C-section rate be-
tween those whose BW was <2,500 or ≥2500 g (47.1%
vs. 53.1%, P < 0.001). The C-section rate for those with
pregnancy complications was significantly higher (Table 2).
More neonates from C-section had history of abnormal
amniotic fluid quantity, CHD and respiratory distress syn-
drome, required oxygen therapy and mechanical ventila-
tion in contrast to fewer jaundice and cephalohematomathan those from vaginal delivery. From Table 6, more
pregnancy complications, preterm births and low BW
rates, and congenital anomalies (BD) were seen in
those whose maternal age >35 years old. In those
whose age <20 years old, there were also high propor-
tions of preterm births and low BW rates. The average
maternal age was 25.9 ± 5.1 (median 24, range 16–49)
years old, and 2.47% (1,490/60,209) were <20 years old.
Delayed child-bearing (≥35 y) accounted for 8.4% (5,065/
60,209). Table 7 shows high risk pregnancy and perinatal
morbidities in association with maternal school education
years, where 1.5% were illiteracy.
Perinatal complications and hospitalized neonatal patients
There were 6,872 neonates admitted to the ward includ-
ing 4,332 male and 2,540 female (male-to-female ratio
1.71:1), in which 43%, 26.2%, 11.1% and 19.8% were ad-
mitted on day 1, 2–7, 8–14, 15–28, respectively, with
75% of the total as rural origin. In 18.8% of the hospital-
ized neonatal patients, their mother had pregnancy com-
plications [14], and these incidences declined with
increasing BW. For the pregnancy complications before
delivery in the mothers of all hospitalized neonates, 547
(8.0%) had premature rupture of the membrane, 248
(3.6%) fever and infection, 160 (2.3%) hypertension, 105
(1.5%) preeclampsia, 77 (1.1%) placenta previa, 40 (0.6%)
anemia or placenta abruption each, 29 (0.4%) diabetes,
27 (0.4%) liver diseases, 26 (0.4%) hematological dis-
eases, 17 (0.2%) syphyllis, 14 (0.2%) cardiac diseases, 7
systemic lupus erythematosus, 5 renal diseases, 4 epi-
lepsy, 4 hyperthyroidism, 3 hypothyroidism, etc. In the
hospitalized and critically ill neonatal patients, major
diagnoses were severe sepsis and septic shock, diaphrag-
matic hernia, disseminated intravascular coagulation,
pulmonary hemorrhage, cardiac failure, respiratory dis-
tress syndrome, pneumothorax, necrotizing enterocolitis,
each with a mortality of 78.6%, 60%, 60%, 53.8%, 38.9%,
18.9%, 17.0% and 9.1%, respectively. In all these patients,
26.8% received oxygen therapy, 8.6% were mechanically
ventilated, 99.2% treated with antibiotics, 9.3% cortico-
steroids, and 1.3% surfactant therapy, whereas 34.9% re-
covered, 56.2% improved, 4.8% requested own discharge,
2.4% were given up or died, 1.7% transferred to other
hospitals. Average length of hospital stay was 8.5 ±
6.3 days, and average cost of hospital stay was 4,182 ±
4,033 Yuan (CNY, 6.5 = 1 USD in 2010).
Uni- and multi-variate logistic regression analysis of risks
for perinatal mortality
Table 8 illustrates the results from uni- (part A) and
multi-variate (part B) binary logistic regression analysis
of risks of perinatal mortality from clinical variables asso-
ciated with pregnancy complications, perinatal morbidities
and neonatal status. In both uni- and multi-variate logistic
Table 3 Perinatal status and pregnancy complications in neonatal birthweight strata
Birthweight (g) <1,500 1,500-2,499 2,500-3,999 ≥4,000 P values
Birth number (%) 154 (0.3) 1,537 (2.5) 50,450 (83.6) 8,231 (13.6)
Males 73 (48.0) 762 (49.9) 26,133 (52.0) 5,343 (65.3) <0.001
Gestational age (weeks) 30.1±2.9 35.9±2.9 39.7±1.2 40.2±1.0 <0.001
Birthweight (grams) 1,157±238 2,140±269 3,365±333 4,192±250 <0.001
Preterm births 152 (98.7) 950 (62.3) 1,103 (2.2) 26 (0.3) <0.001
Multi-births 28 (18.2) 323 (21.0) 729 (1.4) 23 (0.3) <0.001
Congenital anomalies 11 (7.1) 54 (3.5) 222 (0.4) 27 (0.3) <0.001
Cesarean section rate 43 (28.3) 748 (49.0) 25,629 (50.9) 5,438 (66.2) <0.001
Pregnancy complications 65 (42.2) 476 (31.0) 4,769 (9.4) 710 (8.6) <0.001
Hypertension 12 (7.8) 105 (6.8) 758 (1.5) 133 (1.6) <0.001
PROM 25 (16.2) 236 (15.4) 2,678 (5.3) 336 (4.1) <0.001
Anemia 3 (1.9) 40 (2.6) 590 (1.2) 110 (1.3) <0.001
Maternal age (years) 26.6±6.3 26.3±5.9 25.7±5.1 26.7±5.3 <0.001
Delayed childbearing 22 (14.5) 192 (12.6) 3,971 (7.9) 866 (10.6) <0.001
>9 years’ education 15 (10.9) 256 (18.7) 8,614 (18.4) 1,397 (18.3) 0.151
Amniotic fluid volume <0.001
Normal 123 (83.7) 1,273 (86.9) 45,686 (92.5) 7,608 (94.5)
Polyhydramnios 11 (7.5) 27 (1.8) 331 (0.7) 105 (1.3)
Oligohydramnios 13 (8.8) 165 (11.3) 3,395 (6.9) 342 (4.2)
Amniotic contamination <0.001
Normal 121 (80.1) 1,259 (84.3) 43,144 (86.2) 6,841 (83.9)
Grade I 10 (6.6) 62 (4.1) 2,616 (5.2) 533 (6.5)
GradeII 4 (2.6) 68 (4.5) 2,273 (4.5) 391 (4.8)
Grade III 16 (10.6) 104 (7.0) 2,022 (4.0) 388 (4.8)
Apgar score
1-min ≤7 107 (74.3) 449 (29.7) 1,509 (3.0) 212 (2.6) <0.001
1-min ≤3 59 (41.0) 115 (7.6) 153 (0.3) 17 (0.2) <0.001
5-min ≤7 91 (63.6) 209 (13.9) 209 (0.4) 27 (0.3) <0.001
5-min ≤3 45 (31.5) 88 (5.8) 89 (0.2) 12 (0.1) <0.001
Hospitalization 121 (78.6) 1,209 (78.7) 4,880 (9.7) 637 (7.7) <0.001
Oxygen therapy 103 (66.9) 565 (36.8) 1,043 (2.1) 122 (1.5) <0.001
Mechanical ventilation 67 (43.5) 246 (16.0) 255 (0.5) 23 (0.3) <0.001
Postnatal steroids 10 (6.5) 71 (4.6) 488 (1.0) 72 (0.9) <0.001
Surfactant therapy 18 (11.7) 57 (3.7) 14 1 <0.001
Pneumonia 88 (57.1) 910 (59.2) 2,532 (5.0) 326 (4.0) <0.001
Asphyxia 31 (20.1) 214 (13.9) 504 (1.0) 59 (0.7) <0.001
RDS 56 (36.4) 178 (11.6) 132 (0.3) 4 <0.001
IVH 50 (32.5) 468 (30.4) 670 (1.3) 62 (0.8) <0.001
Hyperbilirubinemia 7 (4.5) 120 (7.8) 1448 (2.9) 202 (2.5) <0.001
Deathsa 55 (35.7) 93 (6.1) 88 (0.2) 10 (0.1) <0.001
All values are numbers and percentage (% of total births in each birthweight category) or means±SD; aincluding fetal deaths/stillbirth and neonatal deaths
immediately at delivery but counted as live births.
Abbreviations: PROM premature rupture of membrane, RDS respiratory distress syndrome, IVH intraventricular hemorrhage.
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Table 4 Perinatal status and pregnancy complications in neonatal gestational age strata
Gestational age (weeks) <32 32-36 37-41 ≥42 P values
All birthsa 302 (0.5) 1,937 (3.2) 56,331 (93.5) 1,694 (2.8)
Males 164 (54.8) 1,076 (56.0) 30,134 (53.8) 838 (49.7) 0.002
Gestational age (weeks) 29.8±1.8 35.3±1.3 39.8±1.0 42.4±0.5 <0.001
Birthweight (g) 1,727±709 2,572±562 3,475±442 3,596±443 <0.001
Low birthweight 258 (85.4) 844 (43.8) 572 (1.0) 6 (0.4) <0.001
Multi-births 37 (12.3) 334 (17.2) 705 (1.3) 9 (0.5) <0.001
Congenital anomalies 25 (8.4) 38 (2.0) 243 (0.4) 7 (0.4) <0.001
Cesarean section 73 (24.6) 960 (49.8) 29,697 (52.8) 1,082 (64.0) <0.001
Pregnancy complications 101 (34.0) 759 (39.3) 5,086 (9.1) 90 (5.3) <0.001
Hypertension 12 (4.0) 127 (6.6) 855 (1.5) 17 (1.0) <0.001
PROM 54 (17.9) 427 (22.0) 2761 (4.9) 40 (2.4) <0.001
Anemia 4 (1.3) 60 (3.1) 667 (1.2) 14 (0.8) <0.001
Maternal age (years) 26.9±6.3 26.7±5.9 25.8±5.1 25.1±5.0 <0.001
Delayed childbearing 45 (15.0) 262 (13.6) 4,601 (8.2) 125 (7.4) <0.001
>9 years’ education 41 (15.4) 364 (21.4) 9,732 (18.6) 171 (10.8) <0.001
Amniotic fluid volume <0.001
Normal 242 (84.6) 1,651 (90.1) 51,189 (92.8) 1,484 (89.3)
Polyhydramnios 17 (5.9) 35 (1.9) 410 (0.7) 10 (0.6)
Oligohydramnios 27 (9.4) 147 (8.0) 3,561 (6.5) 168 (10.1)
Amniotic contamination <0.001
Normal 239 (81.3) 1,679 (89.3) 48,041 (86.0) 1,295 (77.1)
Grade I 15 (5.1) 70 (3.7) 2,986 (5.3) 140 (8.3)
Grade II 5 (5.1) 56 (3.0) 2,543 (4.6) 121 (7.2)
Grade III 25 (8.5) 75 (4.0) 2,305 (4.1) 124 (7.4)
1-min Apgar ≤7 187 (64.5) 463 (24.3) 1,561 (2.8) 62 (3.7) <0.001
1-min Apgar ≤3 98 (33.8) 99 (5.2) 143 (0.3) 5 (0.3) <0.001
5-min Apgar ≤7 152 (52.4) 179 (9.4) 198 (0.4) 8 (0.5) <0.001
5-min Apgar ≤3 80 (27.6) 75 (3.9) 72 (0.1) 4 (0.2) <0.001
Hospitalized rate 208 (68.9) 1,445 (74.6) 4,961 (8.8) 123 (7.3) <0.001
Oxygen therapy 156 (51.7) 656 (33.9) 966 (1.7) 36 (2.1) <0.001
Mechanical ventilation 111 (36.8) 253 (13.1) 206 (0.4) 9 (0.5) <0.001
Surfactant therapy 33 (10.9) 49 (2.5) 8 (0) 0 (0) <0.001
Pneumonia 167 (55.3) 1,064 (54.9) 2,494 (4.4) 69 (4.1) <0.001
Asphyxia 59 (19.5) 232 (12.0) 493 (0.9) 16 (0.9) <0.001
RDS 92 (30.5) 183 (9.4) 90 (0.2) 0 (0) <0.001
Deathsb 93 (30.9) 76 (4.0) 73 (0.1) 4 (0.2) <0.001
Values are given in numbers and percentage (% of all births in each gestational age category) or mean±SD. aPercentage of total numbers of all births, including
fetal death/stillbirths and neonatal death at delivery (see Table 1); bincluding fetal deaths/stillbirth and neonatal deaths immediately at delivery but counted as
live births.
Abbreviations: PROM premature rupture of membrane; Apgar, Apgar score of life signs; RDS, respiratory distress syndrome.
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http://www.biomedcentral.com/1471-2393/14/338regression analysis, BD, low GA and BW are the three
most significant contributing factors, indirectly reflecting
the influence of pregnancy complications and other peri-
natal risks, whereas gender was not a contributing factor.Discussions
This study estimated impact of overall high risk preg-
nancy and delivery at three levels of hospitals based on
data file from complete birth population, stratified GA
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http://www.biomedcentral.com/1471-2393/14/338and BW of the neonates, and maternal mode of delivery,
age and education, confirmed by uni- and multivariate
logistic regression analyses of the risks of perinatal deaths.
These results are evidences linking the major pregnancy
complications to perinatal and neonatal morbidity and
mortality, accounting in part for all the hospitalized neo-
nates, and should be regarded as benchmark in this study
field. These results should also be complementary to our
previous report on perinatal and neonatal mortalities,
premature birth rate, and consist of a detailed descrip-
tion of the perinatal care and delivery in a regional
Chinese perinatal care system [14], and to the under-
standing of previous reports on the trend of neonatal
mortality in China in comparison with the worldwide
development [1-8]. The 151 level I-III hospitals in this
region served for >60,000 annual deliveries from 5.4
millions of population, and their capacity and quality
were very representative and close to average of the
emerging regions in east and mid-land provinces of the
country.
There was a clear trend of high risk pregnancy and
delivery among three levels of hospitals in this region as
reflected by differences of BD, preterm births, multiple
births, congenital anomalies, pregnancy complications,
and stress of fetus and newborns at delivery. It is possible
that there was limitation at low level hospitals in distin-
guishing these situations in daily practice, however, this
was the first time reported as fetal death and stillbirth rate
from Chinese regional complete data files of regional birth
registry. There was a clear trend that higher pregnancy
complications and fetal deaths (including stillbirth) and
early neonatal death were found mainly in the level II and
III hospital deliveries (Table 1). The mothers in the level
III hospitals had 2–4 times as high the pregnancy com-
plications contributing to fetal and neonatal adverse
outcome and morbidity as those in the level I hospitals
(Table 1). The 10% pregnancy complications in the whole
births of this survey is similar to 11% in a previous, small
scale survey of 5,822 live births in 2006–2007 in Julu
county hospitals, of approximate 400,000 population,
Hebei province, one of the coastal regions in China
[18]. The specific pregnancy complications in this sur-
vey, such as pregnant associated hypertention and pre-
eclampsia, anemia, placenta previa, diabetes and
others, were lower than that in the international and
domestic levels [19-24]. As 85% of the total deliveries
were at level I and II hospitals with variable, but
substantial, incidence of pregnancy complications,
challenge exists as to inappropriate diagnosis and
underreporting, and to what magnitude the overall
perinatal risks may be reduced in association with mul-
tiple factors such as facilities, caregiver competence,
service standard, health insurance, and socioeconomic
and socio-cultural aspects, etc.There is possibility that incidence of pregnancy com-
plications in all the deliveries from the level I hospitals
may be underreported even if the medical care for the
complications was available there. Mechanisms under-
lying such situation were due to insufficient clinically
diagnostic experience and management or inappropriate
response for concerns of liability from more reporting of
the pregnancy complications. Nevertheless, this would
be common in regions where perinatal care system is
not properly organized, and criteria for diagnosis and
management of major pregnancy morbidities and com-
plications were not uniformly executed [7,8,10,13].
These imply bias due to inappropriate diagnosis and
incomplete data collection from some lower level hospi-
tals, hence is direction of improvement in local infra-
structure of perinatal and medical care for those with
pregnancy complications, and information reporting sys-
tem. Although in some well developed prefectural re-
gions of the coastal provinces (such as in Zhejiang),
delivery at level I hospital is no longer eligible in recent
years, the delivery at level I hospital should remain for
substantial proportion (20-40%) of rural residents, espe-
cially in regions of low economic development and poor
perinatal care conditions [11,12].
Mode of delivery was apparently associated with risks
due to pregnancy complications [25-27] (Table 5). Those
with C-section delivery had higher rate of pregnancy
complications, especially premature rupture of the mem-
brane and hypertension whereas multiple pregnancy and
abnormal amniotic fluid volume were also associated.
High C-section deliveries at level I and II hospitals should
have contributed considerably to the overall C-section
rate, in which the non-medical indication related might
be accounted for a substantial proportion, indicating it
necessary to standardize routine service at lower level
obstetrics. Our current data reveal that a high C-section
rate above 50% was seen in those with maternal age
20–34 years, no pregnancy complications, no BD or
congenital anomalies, no amniotic fluid contaminations
or abnormal volume, suggesting substantial numbers of
delivery by C-section had no medical indications, or as
low risk pregnancy. The morbidity in the neonates hospi-
talized tended to be severe and complicated in C-section
deliveries as more required oxygen therapy and mechan-
ical ventilation, and more respiratory distress syndrome
and CHD were found. Although those delivered at level I
and II hospitals accounted for almost 2/3 of pregnancy
complications in the total (Table 1), as we did not have
the data on severity of pregnancy complications in these
hospitals, more severe pregnancy complications should
have been centered and managed in the level III hospitals.
This trend should have been more prominent and relevant
in the emerging regions, requiring advanced perinatal care
system emphasizing on routine screening services for risk
Table 5 Mode of delivery related perinatal status, complications and neonatal morbidities
Mode of delivery Vaginalb Cesarean section P values
All birthsa 28,481 (47.1) 31,964 (52.9)
Males 14,683 (51.8) 17,640 (55.4) <0.001
Gestational age (weeks) 39.6±1.6 39.7±1.4 <0.001
Birthweight (grams) 3,387±475 3,488±500 <0.001
Preterm births 1,191 (4.2) 1,033 (3.2) <0.001
Low birthweight 887 (3.1) 791 (2.5) <0.001
Multi-births 242 (0.9) 844 (2.6) <0.001
Congenital anomalies 142 (0.5) 171 (0.5) 0.519
Pregnancy complications 1,715 (6.0) 4,315 (13.5) <0.001
Hypertension 215 (0.8) 797 (2.5) <0.001
PROM 1,045 (3.7) 2,234 (7.0) <0.001
Anemia 273 (1.0) 470 (1.5) <0.001
Maternal age (years) 25.5±5.0 26.2±5.2 <0.001
Delayed childbearing 2,110 (7.5) 2,948 (9.3) <0.001
>9 years’ education 4,451 (16.8) 5,851 (19.8) <0.001
Amniotic fluid volume <0.001
Normal 26,999 (96.5) 27,774 (89.1)
Polyhydramnios 150 (0.5) 325 (1.0)
Oligohydramnios 837 (3.0) 3,072 (9.9)
Amniotic contamination <0.001
Normal 24,569 (86.6) 26,877 (85.1)
Grade I 1,476 (5.2) 1,753 (5.6)
Grade II 1,146 (4.0) 1,594 (5.0)
Grade III 1,178 (4.2) 1,354 (4.3)
Apgar score
1-min ≤7 1,253 (4.4) 1,024 (3.2) <0.001
1-min ≤3 256 (0.9) 88 (0.3) <0.001
5-min ≤7 367 (1.3) 170 (0.5) <0.001
5-min ≤3 189 (0.7) 42 (0.1) <0.001
Hospitalization 3,137 (11.0) 3,715 (11.6) 0.019
Oxygen therapy 777 (2.7) 1,056 (3.3) <0.001
Mechanical ventilation 205 (0.7) 387 (1.2) <0.001
Postnatal corticosteroids 284 (1.0) 358 (1.1) 0.076
Surfactant use 34 (0.1) 56 (0.2) 0.047
Pneumonia 1,779 (6.2) 2,080 (6.5) 0.098
Jaundicec 892 (3.1) 887 (2.8) 0.010
Asphyxia 357 (1.3) 451 (1.4) 0.092
Intraventricular hemorrhage 593 (2.1) 655 (2.1) 0.776
Hypoxic-ischemic encephalopathy 557 (2.0) 711 (2.2) 0.021
Sepsis 736 (2.6) 815 (2.5) 0.789
Congenital heart disease 183 (0.6) 340 (1.1) <0.001
Respiratory distress syndrome 123 (0.4) 248 (0.8) <0.001
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Table 5 Mode of delivery related perinatal status, complications and neonatal morbidities (Continued)
Cephalohematoma 216 (0.8) 39 (0.1) <0.001
ABO hemolysis 105 (0.4) 108 (0.3) 0.285
Deathsd 202 (0.7) 42 (0.1) <0.001
Values are given in numbers and percentage (% of all births in each delivery category) or mean±SD. aPercentage of total numbers of all births, including fetal
death/stillbirths and neonatal death at delivery (see Table 1); bincluding 397 with assisted operation procedures; cincluding hyperbilirubinemia; dincluding fetal
deaths/stillbirth and neonatal deaths immediately at delivery but counted as live births.
Abbreviations: PROM premature rupture of membrane, Apgar Apgar score of life signs.
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http://www.biomedcentral.com/1471-2393/14/338factors associated with adverse pregnancy along with a
close follow-up for pregnancy women at risk of observed
pregnancy complications during prenatal care to minimize
risk of pregnancy complications, hence possibility of
C-section delivery reduction.Table 6 Maternal age related perinatal status and complicatio
Maternal age, years <20
Live births, n (%)a 1,490 (2.5)
Males 761 (51.2)
Gestational age (weeks) 39.7±1.7
Birthweight (grams) 3,329±478
Preterm birth rate 74 (5.0)
Low birthweight 56 (3.8)
Multi-births 18 (1.2)
Congenital anomalies 5 (0.3)
Cesarean section rate 672 (45.1)




Maternal age (years) 18.6±0.6







Grade I 93 (6.3)
Grade II 84 (5.7)
Grade III 58 (3.9)
Apgar score
1-min ≤7 69 (4.6)
1-min ≤3 14 (0.9)
5-min ≤7 22 (1.5)
5-min ≤3 13 (0.9)
Deathsb 10 (0.7)
Values are given in numbers and percentage (% of live births in each maternal age
bincluding fetal deaths/stillbirth and neonatal deaths immediately at delivery but co
Abbreviations: PROM premature rupture of membrane.The social, cultural and economic factors may have in-
fluenced the regional perinatal and neonatal outcome.
This study focused on mode of delivery, maternal age and
education status. Maternal age should be an overt factor
contributing to perinatal risks and neonatal outcomens
20-34 ≥35 P values
53,654 (89.1) 5,065 (8.4)
28,667 (53.7) 2,763 (54.8) 0.054
39.7±1.5 39.4±1.7 <0.001
3,442±485 3,465±552 <0.001
1,847 (3.5) 307 (6.1) <0.001
1,406 (2.6) 214 (4.2) <0.001
939 (1.8) 121 (2.4) 0.001
273 (0.5) 33 (0.7) 0.245
28,141 (52.6) 2,948 (58.3) <0.001
5,162 (9.6) 717 (14.2) <0.001
795 (1.5) 200 (3.9) <0.001
2,920 (5.4) 280 (5.5) 0.757
637 (1.2) 89 (1.8) 0.002
24.9±3.6 38.0±2.5 <0.001
9,827 (19.7) 401 (8.5) <0.001
0.005
48,608 (92.6) 4,568 (92.3)
396 (0.7) 61 (1.2)
3,490 (6.6) 318 (6.4)
<0.001
45,731 (86.0) 4,245 (84.6)
2,843 (5.3) 267 (5.3)
2,412 (4.5) 234 (4.7)
2,196 (4.1) 269 (5.4)
1,961 (3.7) 249 (4.9) <0.001
280 (0.5) 52 (1.0) <0.001
443 (0.8) 73 (1.5) <0.001
181 (0.3) 40 (0.8) <0.001
203 (0.4) 34 (0.7) 0.002
category) or mean±SD; aPercentage of the total number of all live birth;
unted as live births.
Table 7 Maternal education related perinatal status and complications
Education years >12 10-12 7-9 <7 P values
All birthsa 4,396 (7.8) 5,943 (10.6) 39,702 (70.5) 6,249 (11.1)
Males 2,319 (53.4) 3,056 (51.9) 21,318 (53.9) 3,388 (54.4) 0.017
Gestational age (weeks) 39.5±1.4 39.6±1.5 39.7±1.5 39.6±1.7 <0.001
Birthweight (g) 3,462±472 3,447±485 3,446±485 3,402±524 <0.001
Preterm birth rate 157 (3.6) 248 (4.2) 1,254 (3.2) 307 (5.0) <0.001
Low birthweight 108 (2.5) 163 (2.8) 996 (2.5) 240 (3.8) <0.001
Multi-births 86 (2.0) 93 (1.6) 673 (1.7) 130 (2.1) 0.073
Congenital anomalies 21 (0.5) 34 (0.6) 190 (0.5) 47 (0.8) 0.041
Cesarean section 2,609 (59.6) 3,242 (54.7) 20,657 (52.1) 3,093 (49.6) <0.001
Pregnancy complications 634 (14.6) 715 (12.1) 3,310 (8.4) 616 (9.9) <0.001
Pregnant hypertension 72 (1.6) 104 (1.7) 594 (1.5) 157 (2.5) <0.001
PROM 432 (9.8) 427 (7.2) 1,827 (4.6) 258 (4.1) <0.001
Pregnant anemia 44 (1.0) 92 (1.5) 420 (1.1) 93 (1.5) <0.001
Maternal age (years) 26.8±3.0 25.5±4.3 25.3±4.9 28.9±7.0 <0.001
Delayed childbearing 106 (2.4) 295 (5.0) 2,713 (6.9) 1,590 (25.5) <0.001
Amniotic fluid volume 0.259
Normal 3,856 (92.1) 5,395 (93.5) 36,223 (92.9) 5,665 (92.6)
Polyhydramnios 31 (0.7) 34 (0.6) 283 (0.7) 47 (0.8)
Oligohydramnios 298 (7.1) 344 (6.0) 2,492 (6.4) 406 (6.6)
Amniotic contamination <0.001
Normal 3,750 (87.5) 5,083 (86.7) 33,942 (86.1) 5,283 (85.1)
Grade I 170 (4.0) 253 (4.3) 2,154 (5.5) 372 (6.0)
Grade II 150 (3.5) 247 (4.2) 1,816 (4.6) 303 (4.9)
Grade III 218 (5.1) 283 (4.8) 1,518 (3.8) 250 (4.0)
1-min Apgar ≤7 219 (5.0) 195 (3.3) 1,413 (3.6) 269 (4.3) <0.001
1-min Apgar ≤3 16 (0.4) 26 (0.4) 207 (0.5) 68 (1.1) <0.001
5-min Apgar ≤7 44 (1.0) 37 (0.6) 308 (0.8) 92 (1.5) <0.001
5-min Apgar ≤3 8 (0.2) 16 (0.3) 145 (0.4) 49 (0.8) <0.001
Deathsb 8 (0.2) 17 (0.3) 155 (0.4) 55 (0.9) <0.001
Values are given in numbers and percentage (% of all births in each maternal education year category) or mean±SD. aPercentage of total numbers of all births,
including fetal death/stillbirths and neonatal death at delivery (see Table 1); bincluding fetal deaths/stillbirth and neonatal deaths immediately at delivery but
counted as live births.
Abbreviations: PROM premature rupture of membrane, Apgar Apgar score of life signs.
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http://www.biomedcentral.com/1471-2393/14/338[28-32]. In those with early (<20 years old) and delayed
(≥35 y) child bearing, relatively higher preterm birth rate
(5% and 6.1%, respectively) were found (Table 6), along with
higher rate of BD, pregnancy complications, C-section rate,
lower Apgar score at 1- and 5 min, neonatal deaths rate,
mainly seen in those ≥35 y. Maternal education years also
had impact on pregnancy complications and neonatal
outcome [33]. We found those with education <7 years
had relatively higher percentage of delayed child bearing
age (i.e., having more than 2 children), preterm births,
low BW, lower Apgar score at 1- and 5 min, neonatal
deaths rate (Table 7). It is reported that the incidence of
fetal and infant mortality were inversely related to ma-
ternal educational gradient: higher with a lower level ofeducation, a determinant of the incidence of fetal and
post-neonatal death but not of early and late neonatal
death (0–27 days) [33]. Taking the results from uni- and
multi-variate logistic regression analysis, pregnancy com-
plications as well as multiple births, BD, and perinatal
morbidities and mothers’ biological and social status were
significantly associated with the perinatal and neonatal
outcome, indirectly reflecting the influence of pregnancy
complications and other perinatal risks.
For limitation and implication of the study, as discussed
above, in addition to incomplete data from lower level
clinics, there are several major limitations of the data
presentation. First, there is a lacking of causal relation-
ship between those of maternal complications and
Table 8 Uni- and multi-variate regression analysis of risk factors for perinatal mortality
A. Uni-variate regression analysis for perinatal mortality
Variables Category Mortality (%)* OR 95% CI P values
Gender Male 0.4 1.154 0.898-1.481 0.262
Female 0.4
Multi-births No 0.4 3.984 2.426-6.543 <0.001
Yes 1.5
Congenital anomalies No 0.3 74.260 54.067-101.996 <0.001
Yes 19.2
Pregnancy complications No 0.4 2.496 1.844-3.377 <0.001
Yes 0.9
Birthweight (grams) ≥2500 0.2 57.700 44.478-74.852 <0.001
<2500 8.8
Gestational age (weeks) ≥37 0.1 61.782 47.019-81.180 <0.001
<37 7.6
Maternal education (years) ≥10 0.2 1.888 1.247-2.860 0.002
<10 0.5
Maternal age (years) <35 0.4 1.743 1.212-2.506 0.002
≥35 0.7
Amniotic contamination No 0.2 8.374 6.454-10.864 <0.001
Yes 1.6
Amniotic fluid volume Normal 0.3 4.894 3.661-6.542 <0.001
Abnormal 1.5
B. Multi-variate regression analysis for perinatal mortality
95% CI
Variables Reference** OR Lower Upper P values
Gender Male 1.240 0.896 1.715 0.194
Multi-births No 2.396 1.196 4.799 0.014
Congenital anomalies No 35.200 20.304 61.026 <0.001
Pregnancy complications No 1.900 1.215 2.969 0.005
Birthweight (grams) ≥2500 5.397 3.458 8.442 <0.001
Gestational age (weeks) ≥37 32.305 20.463 50.998 <0.001
Education years ≥10 1.789 1.058 3.027 0.030
Maternal age (years) <35 1.133 0.694 1.847 0.618
Amniotic contamination No 10.995 7.824 15.452 <0.001
Amniotic fluid volume Normal 2.354 1.583 3.502 <0.001
*Mortality denotes those numbers of fetal deaths, stillbirths and early neonatal deaths in each category based on the total numbers of deaths listed in Table 1, 2,
3, 4, 5, 6 and 7.
**As references of the opposite category of corresponding variables in this table part A.
Abbreviations: OR odds ratio, CI confidence interval of OR.
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http://www.biomedcentral.com/1471-2393/14/338corresponding neonatal outcome. Secondly, there is a
lacking of clues for severity of the pregnancy complica-
tions and their child delivery hospital levels. To analyze
and understand these relationships, it may help to define
the function and capacity of perinatal care at level II and
III hospital, and standardize the care with license for
maternal and neonatal care, corresponding delivery and
medical facilities, potentiating enormous social healthcost-effectiveness assessment and follow-up analysis in
clinical economics. Thirdly, the study results do not reflect
efficacy of specific measurements in the regional perinatal
care system with local conditions that might have re-
stricted more efficient infrastructure building up. For
example, delivery was disseminated in 129 level I hospi-
tals, and low Apgar score and neonatal deaths were still
present to certain extent in all the births. Acquisition of
Sun et al. BMC Pregnancy and Childbirth 2014, 14:338 Page 13 of 14
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when we scrutinized 20% of the reported case records of
all the births during the two major inspections of the
survey, suggesting that the centralized deliveries at level
II and III hospitals, and some upgraded level I hospitals,
should be the direction of future development of the
regional perinatal care system. Although the data may
not be used to predict single hospital service quality, it
may be used to compare different regions in health care
standard and development. We consider current survey
should be replicable from different regional data file to
provide more reliable and comprehensive estimation of
perinatal and neonatal morbidity and mortality and
related high risk pregnancy, including cohort study of
high risk pregnancy, delivery and neonatal outcome.
Conclusion
In conclusion, this survey demonstrates pregnancy
complications and related perinatal morbidity as risk
factors impacting on neonatal outcome, associated with
hospital levels, maternal status, mode of delivery and
major neonatal pathologies. We anticipate that more
surveys are needed using the same concept and meth-
odology in different regions to generate more compre-
hensive database and explore causal relations of high
risk pregnancy to neonatal care and outcome, thereby
ensuring development of measures and programs for
the improvement by perinatal and neonatal care givers,
policy makers and administrators for woman and infant
health.
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